Who Supplies Losartan to India from MALTA

To import finished pharmaceutical formulations containing Losartan into India, the foreign manufacturer must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The application process involves submitting detailed product information, manufacturing licenses, and quality control data. The registration certificate is valid for three years from the date of issue. The Import License is also valid for three years and is required for each import consignment. The application process typically takes several months, depending on the completeness of the submitted documentation.

Imported Losartan formulations must undergo quality testing at CDSCO-approved laboratories. This includes batch-wise testing, submission of Certificates of Analysis (CoA), and stability data demonstrating compliance with Indian Pharmacopoeia standards. The stability data should adhere to ICH Zone IV guidelines. Port inspection by customs drug inspectors is mandatory to ensure compliance with Indian regulations.

In April 2025, the Indian government introduced new regulations requiring import registration and licenses for all imported medicines, including finished formulations. This measure aims to prevent the sale of unapproved or illegal medicines in the Indian market. The Central Drugs Standard Control Organization (CDSCO) emphasized that all imported drugs must meet quality, safety, and efficacy standards.

India imports finished Losartan formulations to meet the demand for branded or patented products, specific dosage forms, and formulations not produced domestically. The domestic capacity may not fulfill the entire market demand, leading to reliance on imports. The market size for Losartan formulations in India is substantial, with imports contributing significantly to the supply.

The import duty for Losartan formulations under HS Code 30049073 includes a Basic Customs Duty of 10%, a Social Welfare Surcharge (SWS) of 10%, and an Integrated Goods and Services Tax (IGST) of 12%. Anti-dumping duties may apply if the Directorate General of Trade Remedies (DGTR) imposes them. Exemption notifications may be issued by the government, reducing or eliminating certain duties. The total landed duty percentage varies based on the product's CIF value and applicable exemptions.

India sources finished Losartan formulations from Malta due to competitive advantages such as patented formulations, specialized dosage forms, and high-quality manufacturing standards. Malta's pharmaceutical industry is known for its adherence to international quality standards, making it a reliable supplier. Other suppliers include China, Germany, and the United States, but Malta's unique advantages position it favorably in the Indian market.

India imports finished Losartan formulations from Malta due to the availability of patented formulations, specialized dosage forms, and high-quality manufacturing standards. Malta's pharmaceutical industry adheres to international quality standards, ensuring the safety and efficacy of the products. Certain formulations containing Losartan may not be manufactured domestically, necessitating imports to meet market demand.

When compared to other origins such as China, Germany, and the United States, Malta offers competitive advantages in terms of quality, regulatory compliance, and reliability. Malta's adherence to international quality standards and its reputation for producing high-quality pharmaceutical products make it a preferred source for finished Losartan formulations.

Indian importers face potential risks when sourcing finished Losartan formulations from Malta, including single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. To mitigate these risks, importers should consider diversifying their supplier base, monitoring currency exchange rates, staying updated on regulatory changes, and establishing contingency plans for potential disruptions.

1. 1Dual-Sourcing: Engage multiple suppliers to reduce dependency on a single source.
2. 2Inventory Planning: Maintain optimal inventory levels to buffer against supply chain disruptions.
3. 3Payment Terms: Negotiate favorable payment terms, such as Letters of Credit (LC), Documents Against Acceptance (DA), or Documents Against Payment (DP).
4. 4Minimum Order Quantities (MOQs): Clarify MOQs with suppliers to ensure flexibility in procurement.
5. 5Supplier Qualification: Conduct thorough due diligence on suppliers to ensure compliance with quality and regulatory standards.

Implementing these strategies can enhance procurement efficiency and mitigate potential risks associated with importing finished Losartan formulations from Malta.

1. 1DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
2. 2CDSCO Registration: Register the manufacturing premises and the drug with CDSCO.
3. 3Import License Application: Apply for an Import License under Form 10.
4. 4No Objection Certificate (NOC): Obtain an NOC from the Ministry of Health and Family Welfare, if required.
5. 5Customs Broker: Engage a licensed customs broker for clearance procedures.
6. 6Advance Ruling: Seek an advance ruling for HS Code 30049073 to confirm classification and applicable duties.

Ensuring compliance with these requirements is essential for the legal importation of finished Losartan formulations into India.

1. 1Certificate of Analysis (CoA): Demonstrates product quality and compliance with specifications.
2. 2Certificate of